FDA Approves BILDYOS® and BILPREVDA®, Biosimilars to PROLIA and XGEVA

The US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), biosimilars to PROLIA and XGEVA, res...